Brind.

Natera offers molecular testing services globally and operates a cinema advertising network in North America.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Natera

Keep exploring

The entities involved

Natera
company in San Carlos, United States
- Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.Mon 02:47
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44

Coverage

Newest first; wire copies grouped

Jul 31Simply Wall St.High Growth Tech Stocks in the US for July 2025 In the last week, the market has been flat, but it is up 16% over the past year with earnings forecast to grow by 15% annually. In this context of stea